Must Read Rumors

Kate Middleton new pregnancy rumor isn’t ‘official’ yet

A new tabloid report claims that the royal mother-of-two is expecting.

Pippa Middleton and James Matthews’ wedding: all the details revealed

Kate Middleton’s younger sister married financier James Matthews at St. Mark’s Church in Englefield on Saturday in what has been dubbed “the wedding of the year.”

Pippa Middleton wedding: why Kate isn’t likely to be maid of honor

As the big day is getting near, the question of who will be Pippa’s maid of honor is gathering attention since it seems that Kate Middleton wont fill in that role.

Pippa Middleton wedding dress details revealed

A week from now Duchess Kate’s sister will be walking down the aisle and her gown will undoubtedly turn heads all over the world.

Kate Middleton stuns in blue coat during Luxembourg visit

On her first visit to Luxembourg, Duchess Kate stole everyone’s hearts.

Kate Middleton new pregnancy rumor isn’t ‘official’ yet
Pippa Middleton and James Matthews’ wedding: all the details revealed
Pippa Middleton wedding: why Kate isn’t likely to be maid of honor
Pippa Middleton wedding dress details revealed
Kate Middleton stuns in blue coat during Luxembourg visit

The Bluetooth pill to appear in European hospitals soon

by Nicole
November 12, 2010 at 3:22 pm

Miniaturization has always been a safe way to remarkable advances in microprocessor industry, allowing not only the manufacturing of microchips, but also a greater degree of integration for equipment with a high degree of complexity.

One of the areas that most benefit this is medicine, a domain in which miniaturization has enabled the creation of more sophisticated prostheses, and intelligent diagnostic equipment, small enough to fit inside a capsule.

One of the first companies to bring such devices in mass production is Novartis AG Sweden, with its “Ingestible Event Marker.” Small enough to be incorporated into the pill capsules, this microchip, activated after ingestion by contact with the stomach acids, may send biometric information to assess the effectiveness of the administered drug.

Parameters such as body temperature, heart rate and movements of the patient can be monitored, as information is transmitted in real time via Bluetooth.

Initially, this technology will be used only for monitoring high-risk patients such as those undergoing transplant operations, but could be extended to other areas.

If tests show that adding such microchips does not change the curative properties of pills, the product could be approved for general use in European countries over the next 18 months.

What do you think? What is your gossip?

The rules: Keep it clean, stay on the subject and use English only - or we may delete your comment. If you see inappropriate language email us. Read our Terms and Conditions